Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma

Quaglia, Alberto and McStay, M. and Stoeber, Kai and Loddo, Marco and Caplin, M. and Fanshawe, Thomas and Williams, Gareth and Dhillon, A.P. (2006) Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma. Liver International, 26 (4). pp. 424-432. ISSN 1478-3231

Full text not available from this repository.

Abstract

Background: We investigated cell cycle kinetics of nodular lesions in cirrhosis to differentiate hepatocellular carcinoma (HCC) from its precursor lesions. Methods: Twelve small HCC, 10 regenerative (RN), six large regenerative (LRN), and five dysplastic nodules (DN), identified in explant cirrhotic livers of five consecutive patients transplanted at Royal Free Hospital in 2002. Immunoperoxidase for MCM2, geminin and Ki67 was performed and the percentage of positive cells counted. Results: The proportion of cells expressing MCM2 was more than those expressing Ki67, which in turn was more than those expressing geminin (overall median=16%, 2% and 0.5%, respectively, P<0.001). There was a statistically significant trend of increasing Ki67 expression (P=0.006), from RN to HCC; this trend was not statistically significant for geminin (P=0.18) or MCM2 (P=0.51). The median percentage of cells expressing Ki67 was 1% in RN, 0.5% in LRN, 2.2% in DN and 5.4% in HCC. The combination of these markers identified four different cell kinetics patterns: ‘resting’ (G0 cells: MCM2 −ve, Ki67 −ve, geminin −ve); ‘licensed’ (MCM2 +ve, Ki67 −ve, geminin −ve); ‘slowly growing’ (G1 phase arrest, MCM2 +ve, Ki67 +ve, low (0.4%) geminin) and expanding (MCM2 +ve, Ki67 +ve, geminin +ve) nodules. Conclusions: The combination of MCM2, geminin and Ki67 could represent a valuable tool in the understanding of HCC progression in cirrhosis.

Item Type:
Journal Article
Journal or Publication Title:
Liver International
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700/2721
Subjects:
?? cell cycledna licensing dysplastic nodule geminin hepatocellular carcinoma ki67 large regenerative nodule mcm2hepatology ??
ID Code:
50586
Deposited By:
Deposited On:
01 Nov 2011 10:15
Refereed?:
Yes
Published?:
Published
Last Modified:
15 Jul 2024 12:25